WHO approves China's Sinovac coronavirus vaccine

Published June 1, 2021
The Sinovac jab is already in use in 22 territories around the world. — AFP/File
The Sinovac jab is already in use in 22 territories around the world. — AFP/File

The World Health Organisation on Tuesday approved the Sinovac Covid-19 vaccine for emergency use — the second Chinese jab to receive the WHO's green light.

The UN health agency signed off on the two-dose vaccine, which is already being deployed in several countries around the world, including Pakistan.

“WHO today validated the Sinovac-CoronaVac Covid-19 vaccine for emergency use,” it said in a statement.

The move gives countries, funders, procuring agencies and communities “assurance that it meets international standards for safety, efficacy and manufacturing”.

Last month, Sinopharm became the first Chinese vaccine to be approved by the WHO.

The organisation has also given emergency use listing to vaccines being made by Pfizer/BioNTech, Moderna, Johnson & Johnson, and the AstraZeneca jab being produced in India, South Korea and the EU, which it counts separately.

WHO's listing paves the way for countries worldwide to quickly approve and import a vaccine for distribution, especially those states without an international-standard regulator of their own.

It also opens the door for the jabs to enter the Covax global vaccine-sharing scheme, which aims to provide equitable access to doses around the world, particularly in poorer countries.

Currently only AstraZeneca and some Pfizer jabs are flowing through the scheme.

“The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe,” said Mariangela Simao, the WHO's assistant director general for access to health products.

“We urge manufacturers to participate in the Covax facility, share their know-how and data and contribute to bringing the pandemic under control.”

The Sinovac jab is already in use in 22 territories around the world, according to an AFP count.

Apart from China, the countries using Sinovac include Chile, Brazil, Indonesia, Mexico, Thailand and Turkey.

The WHO's Strategic Advisory Group of Experts on Immunisation have reviewed the jab and published their advice on its usage.

“WHO recommends the vaccine for use in adults 18 years and older, in a two-dose schedule with a spacing of two to four weeks,” the agency said.

“Vaccine efficacy results showed that the vaccine prevented symptomatic disease in 51 per cent of those vaccinated and prevented severe Covid-19 and hospitalisation in 100pc of the studied population.”

Sinovac is one of three Chinese vaccines approved by Pakistan and is currently being administered across the country. On May 23, a special Pakistan International Airlines (PIA) flight brought two million Sinovac doses purchased by Pakistan from China to the country.

A week before that, a special flight PK-6852 had transported a consignment of one million doses of Sinovac vaccine from Beijing.

Opinion

Sub judice rule
18 Sep 2021

Sub judice rule

It is time this objection, sub judice, is laid to rest.
The Black Caps folly
Updated 18 Sep 2021

The Black Caps folly

There is so much wrong — and worrying — about the entire sorry episode of New Zealand backing out of Pakistan tour.
CT NAP revisited
Updated 18 Sep 2021

CT NAP revisited

A policy of appeasement towards extremists has undermined the state’s writ.
Pathways for reform
Updated 17 Sep 2021

Pathways for reform

Even now the government has said they are listening, but they have not said how they are listening.

Editorial

Blinken’s remarks
Updated 18 Sep 2021

Blinken’s remarks

The US establishment cannot scapegoat Pakistan for two decades of bad policy in Afghanistan.
18 Sep 2021

Worrying survey

THE findings of the Labour Force Survey 2018-19 indicate that some important headline trends have already taken or...
18 Sep 2021

Special needs

THE fact that only 3,653 children with special needs, out of some 300,000 in Sindh, are registered with the...
TTP amnesty?
Updated 17 Sep 2021

TTP amnesty?

An amnesty should be for some individuals, not the entire outfit.
17 Sep 2021

Media regulation

THE needless controversy over media regulation may finally be heading for a resolution. In a meeting with ...
17 Sep 2021

Refusing audit

THE continuous resistance put up by several public-sector organisations to submitting their accounts for audit by ...